Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocarditis | 5 | 2011 | 51 | 0.710 |
Why?
|
| Graft Rejection | 6 | 2019 | 1065 | 0.450 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2019 | 272 | 0.420 |
Why?
|
| Heart Transplantation | 5 | 2019 | 705 | 0.400 |
Why?
|
| Cardiac Myosins | 2 | 2008 | 18 | 0.400 |
Why?
|
| Trypanosoma cruzi | 4 | 2011 | 7 | 0.320 |
Why?
|
| Autoimmune Diseases | 3 | 2008 | 241 | 0.310 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2008 | 132 | 0.310 |
Why?
|
| Graft Survival | 4 | 2019 | 884 | 0.290 |
Why?
|
| Autoimmunity | 4 | 2011 | 160 | 0.280 |
Why?
|
| Transplantation Tolerance | 3 | 2016 | 130 | 0.280 |
Why?
|
| Renin-Angiotensin System | 1 | 2007 | 133 | 0.270 |
Why?
|
| Transplantation Immunology | 2 | 2019 | 84 | 0.270 |
Why?
|
| Immune Tolerance | 3 | 2019 | 337 | 0.260 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2016 | 372 | 0.240 |
Why?
|
| Listeriosis | 3 | 2019 | 84 | 0.210 |
Why?
|
| Listeria monocytogenes | 3 | 2019 | 89 | 0.210 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 2232 | 0.200 |
Why?
|
| Staphylococcus aureus | 3 | 2014 | 263 | 0.200 |
Why?
|
| Mice, Inbred BALB C | 7 | 2019 | 1047 | 0.190 |
Why?
|
| Interleukin-17 | 2 | 2014 | 101 | 0.190 |
Why?
|
| Mice | 16 | 2019 | 11356 | 0.190 |
Why?
|
| Staphylococcal Infections | 2 | 2013 | 255 | 0.180 |
Why?
|
| Interleukin-6 | 2 | 2011 | 256 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 8 | 2019 | 3095 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2019 | 295 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2019 | 425 | 0.150 |
Why?
|
| Protozoan Proteins | 2 | 2010 | 73 | 0.150 |
Why?
|
| Animals | 17 | 2019 | 26589 | 0.150 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2007 | 231 | 0.130 |
Why?
|
| Antigen-Presenting Cells | 1 | 2016 | 139 | 0.130 |
Why?
|
| Isoantibodies | 1 | 2016 | 114 | 0.130 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2014 | 25 | 0.120 |
Why?
|
| Antibodies, Bacterial | 1 | 2014 | 95 | 0.120 |
Why?
|
| Dermatitis | 1 | 2013 | 32 | 0.110 |
Why?
|
| Antigens, Protozoan | 2 | 2011 | 21 | 0.110 |
Why?
|
| Immunization | 2 | 2011 | 158 | 0.110 |
Why?
|
| Allografts | 3 | 2019 | 172 | 0.110 |
Why?
|
| Chagas Cardiomyopathy | 2 | 2011 | 4 | 0.100 |
Why?
|
| Th1 Cells | 2 | 2011 | 164 | 0.100 |
Why?
|
| Adoptive Transfer | 3 | 2016 | 168 | 0.100 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 164 | 0.090 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2010 | 4 | 0.090 |
Why?
|
| Trypanosomiasis, African | 1 | 2010 | 6 | 0.090 |
Why?
|
| Parasitemia | 1 | 2010 | 6 | 0.090 |
Why?
|
| Skin Transplantation | 1 | 2011 | 172 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 1 | 2010 | 115 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2011 | 182 | 0.090 |
Why?
|
| Chagas Disease | 1 | 2008 | 3 | 0.080 |
Why?
|
| Hypersensitivity, Delayed | 2 | 2007 | 25 | 0.080 |
Why?
|
| Peptides | 1 | 2012 | 639 | 0.080 |
Why?
|
| Luminescent Measurements | 1 | 2008 | 57 | 0.080 |
Why?
|
| Interleukin-4 | 1 | 2008 | 127 | 0.080 |
Why?
|
| Luciferases | 1 | 2008 | 118 | 0.080 |
Why?
|
| Heart | 1 | 2011 | 539 | 0.080 |
Why?
|
| Captopril | 1 | 2007 | 20 | 0.080 |
Why?
|
| Nitroimidazoles | 1 | 2007 | 8 | 0.080 |
Why?
|
| Losartan | 1 | 2007 | 42 | 0.080 |
Why?
|
| Receptors, Angiotensin | 1 | 2007 | 15 | 0.070 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2007 | 32 | 0.070 |
Why?
|
| Organ Transplantation | 1 | 2011 | 265 | 0.070 |
Why?
|
| Autoantibodies | 2 | 2007 | 267 | 0.070 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2007 | 90 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 1540 | 0.070 |
Why?
|
| Interferon-gamma | 1 | 2008 | 444 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 1014 | 0.070 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2007 | 80 | 0.070 |
Why?
|
| Lymphocyte Activation | 2 | 2016 | 728 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2008 | 2819 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2007 | 977 | 0.050 |
Why?
|
| Th17 Cells | 2 | 2011 | 80 | 0.050 |
Why?
|
| Mice, Congenic | 1 | 2019 | 12 | 0.050 |
Why?
|
| Lymphocyte Transfusion | 1 | 2019 | 41 | 0.050 |
Why?
|
| H-2 Antigens | 1 | 2019 | 58 | 0.040 |
Why?
|
| Isoantigens | 1 | 2019 | 66 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 268 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 158 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 166 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2019 | 152 | 0.040 |
Why?
|
| Cytokines | 2 | 2011 | 778 | 0.040 |
Why?
|
| Myosins | 2 | 2007 | 90 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2019 | 463 | 0.040 |
Why?
|
| Inflammation | 2 | 2011 | 924 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 2012 | 1195 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 307 | 0.030 |
Why?
|
| B7-H1 Antigen | 1 | 2016 | 250 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2016 | 996 | 0.030 |
Why?
|
| Male | 4 | 2008 | 40973 | 0.030 |
Why?
|
| Ovalbumin | 1 | 2012 | 109 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2013 | 790 | 0.030 |
Why?
|
| Epitopes | 1 | 2012 | 255 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 2011 | 66 | 0.020 |
Why?
|
| CD40 Ligand | 1 | 2011 | 69 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 330 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 370 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 736 | 0.020 |
Why?
|
| Female | 4 | 2015 | 44537 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2011 | 194 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2019 | 2207 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 369 | 0.020 |
Why?
|
| Photons | 1 | 2008 | 46 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2062 | 0.020 |
Why?
|
| Binding Sites | 1 | 2010 | 1098 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 3030 | 0.020 |
Why?
|
| Fibrosis | 1 | 2007 | 203 | 0.020 |
Why?
|
| Humans | 4 | 2011 | 86653 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1921 | 0.020 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2004 | 32 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2004 | 106 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2004 | 129 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2010 | 1579 | 0.020 |
Why?
|
| Rats | 1 | 2008 | 3992 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2007 | 7993 | 0.010 |
Why?
|